SGD Week 2 - Abnormal Uterine Bleeding Gr4
SGD Week 2 - Abnormal Uterine Bleeding Gr4
SGD Week 2 - Abnormal Uterine Bleeding Gr4
Uterine
Bleeding
Ferrer, Guarin, Jara, Joson
Objectives
● Present a case of Abnormal Uterine Bleeding (AUB)
● Discuss 4 differential diagnosis
● Discuss briefly the different etiologies of AUB based on FIGO
classification
● Discuss the cause of AUB of the patient as to the following:
○ Incidence
○ Risk factors
○ Pathogenesis
○ Diagnosis
○ Management
General Data Chief Complaint
HEENT: Anicteric sclerae, pink palpebral conjunctiva , (-) nasoaural discharge, (-) tonsillopharyngeal
congestion, (-)cervical lymphadenopathies, (-) palpable neck mass
Chest & Lungs: Symmetrical chest expansion, (-) crackles(-) retractions, vesicular breath sounds, (-) wheezes
Heart: Adynamic precordium, apex beat at 5th LICS MCL, normal rate, regular rhythm, no murmur
Pelvic exam:
Inspection: Normal appearing external female genitalia, no lesions, no erosions, no masses, no varicosities
Speculum Exam: Normal appearing vaginal mucosa, cervix pinkish with smooth surface, no erosions/lesion,
Bimanual Exam: cervix is firm, parrous, uterus not enlarged, no adnexal masses or tenderness noted, with no
bleeding as per examining finger, no cervical motion tenderness
Rectovaginal Examination: Good sphincteric tone, intact rectovaginal septum, parametria pliable, no mass or
nodulations noted
Extremities: Grossly normal extremities, no edema, no cyanosis, no pallor, with bilateral and full equal pulses
at the upper and lower extremities
Salient Features
● A.W., 40 years old, G1P1 (1001), female ● PMH: unremarkable
● Heavy menstrual bleeding, 6-7 pads per day, ● FMH: (+) HTN, (+) DM, (-) Blood dyscrasias
fully soaked lasting for 5 days without ● PSH: unremarkable
accompanying symptoms such as dizziness, ● OB: G1, 2003, Term, NSD, Boy, 3000g
pallor, abdominal pain or dysuria ● GYNE: M: 9 years old
● LMP: January 29, 2023 I: 28-30 days
PMP: December 4th week, 2022 D: 4-5 days
● transvaginal ultrasound (March 2023): normal A: 4-5 ppd, moderately soaked
sized anteverted uterus, thickened S: no associated symptoms
endometrium (1.11 cm) with hyperechoic Coitarche: 18 y/o; 1 sexual partner
structure connected to a single feeding vessel (-) contraceptive use; (-) STI
(0.8 x 0.6 x 0.5 cm) suggestive of endometrial (+) Pap smear (March 2023): unremarkable
polyp, left antero-fundal myoma (2.4 x 2.6 x ● ROS: unremarkable
2.1cm), FIGO 2 ● PE: BMI 28.3 kg/m2 Obese I
Admitting Diagnosis
● NPO
● VENOCLYSIS
● EVENING PRIMROSE
COURSE IN THE WARD
PELVIC EXAMINATION
Intraoperative Findings:
Recovery room
At the ward
Obesity
BMI 28.3 kg/m2 Obese I
Endometrial Cancer
P - Polyp L - Leiomyoma
Growths of endometrial glands Benign tumors that arise from the
and stroma that protrude into the smooth muscle cells of the
uterine cavity - and they’re myometrium, and they’re the most
usually benign. common pelvic tumor in
reproductive age females
A - Adenomyosis M - Malignancy
In females of reproductive,
Endometrial tissue develops
endometrial cancer is rare; and
ectopically in the myometrium - or
cervical cancer is relatively more
the muscular layer of the uterus.
common.
Non-structural Changes
01 02 03
C- Coagulopathy O - Ovulatory E - Endometrial
dysfunction
04 05
I - Iatrogenic N - Not yet
classified
Result of Histopath
AUB P1A0L1M0-C0O0E1I0N0
INCIDENCE
ABO O+
Management